Regulus Therapeutics Inc.

NASDAQ: RGLS · Real-Time Price · USD
8.16
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM

Regulus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
49.46M 38.53M 26.37M 17.18M 29.65M 23.83M 25.83M 37.26M 30.31M 24.23M 20.01M 35.12M 53.9M 60.38M 35.85M 41.44M 31.6M
Short-Term Investments
15.91M 37.25M 60.94M 77.34M 67.97M n/a 4.95M n/a n/a 14.93M 25.31M 12.41M n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 1.47M 10.17M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a 3.2M 3.08M 3.01M n/a n/a n/a n/a n/a n/a 148K 291K n/a n/a n/a
Receivables
n/a n/a n/a n/a -3.01M n/a n/a 3K 4K n/a n/a n/a 8K n/a n/a 194K 72K
Inventory
n/a n/a n/a 3.18M 3.01M 3.01K 3.01K 3.07M 3.07M 3.01K 3.01K 3.01K 3.07M 3.01M 3.01M 3.33M 3.38M
Other Current Assets
2.85M 3.08M 4.38M 62K 62K 62K 62K 62K 62K 62K 62K 62K 62K 62K 62K 62K 62K
Total Current Assets
71.69M 82.34M 91.69M 97.16M 98.44M 25.17M 35.08M 41.36M 34.56M 44.08M 49.37M 51.4M 57.93M 65.23M 39.99M 46.31M 36.54M
Property-Plant & Equipment
3.11M 1.81M 2.05M 2.26M 2.42M 2.54M 2.63M 2.25M 2.4M 2.58M 2.69M 2.83M 2.83M 2.85M 2.97M 3.1M 3.19M
Goodwill & Intangibles
23K 25K 25K 27K 30K 33K 36K 39K 58K 62K 67K 70K 74K 83K 89K 105K 116K
Total Long-Term Assets
3.13M 1.84M 2.08M 6.96M 15.7M 5.58M 2.67M 2.28M 2.45M 2.64M 2.75M 2.9M 3.05M 3.22M 3.06M 3.2M 3.3M
Total Assets
74.83M 84.18M 93.76M 104.12M 114.14M 30.75M 37.75M 43.65M 37.02M 46.72M 52.13M 54.3M 60.98M 68.45M 43.04M 49.52M 39.84M
Account Payables
200K 947K 792K 601K 406K 204K 599K 362K 581K 175K 796K 595K 625K 285K 586K 1.39M 810K
Deferred Revenue
n/a n/a n/a n/a n/a n/a 3.55M 2.91M n/a n/a n/a n/a n/a -589K 4.55M 2.4M 2.15M
Short-Term Debt
n/a n/a n/a n/a 540K 1.33M 2.13M 2.92M 3.72M 4.51M 4.48M 1.65M 826K n/a 4.67M 4.66M 4.66M
Other Current Liabilities
2.24M 5.04M 5.69M 801K 2.25M 2.38M 1.97M 2.04M 2.29M 2.55M 1.85M 619K 957K 1.29M 4.78M 2.75M 3.6M
Total Current Liabilities
4.4M 7.5M 6.48M 5.26M 5.68M 8.51M 8.25M 8.23M 8.82M 11.66M 10.52M 5.83M 4.7M 5.23M 11.46M 9.97M 9.86M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.79M 3.59M 4.67M n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.21M 1.19M 1.18M n/a n/a n/a
Total Long-Term Liabilities
1.4M 274K 476K 675K 868K 1.05M 1.24M 1.42M 1.6M 1.77M 1.94M 6.1M 7.04M 8.27M 2.57M 2.72M 2.87M
Total Liabilities
5.8M 7.77M 6.96M 5.94M 6.55M 9.56M 9.49M 9.65M 10.42M 13.43M 12.46M 11.93M 11.74M 13.5M 14.03M 12.69M 12.73M
Total Debt
1.4M 274K 476K 1.42M 2.14M 3.1M 3.37M 4.34M 5.31M 6.28M 6.41M 6.55M 6.68M 7.09M 7.24M 7.38M 7.52M
Common Stock
66K 66K 66K 65K 65K 20K 20K 19K 17K 17K 17K 15K 146K 146K 87K 87K 75K
Retained Earnings
-569.21M -559.57M -546.78M -532.72M -521.68M -513.21M -505.15M -497.33M -490.31M -483.18M -476.38M -468.83M -461.57M -454.85M -447.72M -439.09M -433.06M
Comprehensive Income
10K 50K n/a -87K -45K -20K -1K -1K -0.00 -12K -31K -36K n/a n/a 0.00 -0.00 n/a
Shareholders Equity
69.03M 76.41M 86.81M 98.18M 107.59M 21.19M 28.26M 34M 26.59M 33.29M 39.67M 42.37M 49.24M 54.96M 29.01M 36.83M 27.11M
Total Investments
15.91M 37.25M 60.94M 78.81M 78.14M n/a 4.95M n/a n/a 14.93M 25.31M 12.41M n/a n/a n/a n/a n/a